In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Illumina Goes Consumer

Executive Summary

Microarray and sequencing specialist Illumina has entered the consumer genomics game with a DTC personal genome sequencing service. It's distancing itself from regulators by partnering with others to handle any secondary data interpretation and dialog with customers, but cautious or not, by reaching out directly to the public, the move does turn on its head the traditional notion of first developing a technology tool for research, then moving on to more regimented clinical applications.
Advertisement

Related Content

With Helix, Illumina Goes Consumer – Again
Which Path Forward For Foundation Medicine?
Clinical Cancer Genomics Gives Bioinformatics Businesses A Boost
The How And When Of Applying Sequencing To Clinical Diagnostics
The How And When Of Applying Sequencing To Clinical Diagnostics
Noninvasive Prenatal Diagnostics: How Much Closer to Reality?
Wireless Health: Personalized Medicine Comes to the Device Industry
Wireless Health: Personalized Medicine Comes to the Device Industry
Illumina Buys Solexa
Illumina Inc.

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV003322

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel